A perioperative study of safusidenib in patients with IDH1 mutated glioma

被引：0

作者：

Whittle, J. R. ^{[1
]}

Rosenthal, M. ^{[1
]}

Spiteri, M. ^{[2
]}

Cain, S. ^{[3
]}

Topp, M. D. ^{[1
]}

Shaya, S. ^{[1
]}

Jones, J. ^{[3
]}

Valkovic, A. ^{[2
]}

Fatunla, O. ^{[2
]}

Dimou, J.

Tobler, R. ^{[2
]}

Roberts-Thomson, S. ^{[4
]}

McArdle, D. ^{[5
]}

Lui, E. ^{[5
]}

Nijagal, B. ^{[6
]}

Grimmond, S. M. ^{[7
]}

Best, S. A. ^{[2
]}

Freytag, S. ^{[2
]}

Drummond, K. ^{[3
]}

机构：

[1] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia

[2] WEHI Walter & Eliza Hall Inst Med Res, Personalised Oncol, Parkville, Vic, Australia

[3] Royal Melbourne Hosp, Neurosurg, Melbourne, Vic, Australia

[4] Royal Melbourne Hosp, Anat Pathol, Melbourne, Vic, Australia

[5] Royal Melbourne Hosp, Radiol, Melbourne, Vic, Australia

[6] Bio21, Metabolom, Melbourne, Vic, Australia

[7] Univ Melbourne, Ctr Canc Res, Ctr Canc Res UMCCR, Victorian Comprehens Canc Ctr, Parkville, Vic, Australia

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.513

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

443O

引用

页码：S407 / S407

页数：1

共 50 条

[31] Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma
Margherita Rimini
Carles Fabregat-Franco
Valentina Burgio
Sara Lonardi
Monica Niger
Mario Scartozzi
Ilario Giovanni Rapposelli
Giuseppe Aprile
Francesca Ratti
Federica Pedica
Helena Verdaguer
Mario Rizzato
Federico Nichetti
Eleonora Lai
Alessandro Cappetta
Teresa Macarulla
Matteo Fassan
Filippo De Braud
Andrea Pretta
Francesca Simionato
Francesco De Cobelli
Luca Aldrighetti
Lorenzo Fornaro
Stefano Cascinu
Andrea Casadei-Gardini
Scientific Reports, 12
[32] MUTANT IDH1 PROMOTES TUMOR-ASSOCIATED EPILEPSY IN GLIOMA PATIENTS
Chen, Hao
Judkins, Jonathon
Ghamsari, Farhad
Lein, Pamela
Horbinski, Craig
NEURO-ONCOLOGY, 2016, 18 : 156 - 156
[33] IDH1 mutation in Balinese glioma patients and its relationship with clinicopathological parameters
Sriwidyani, Ni Putu
Wahyuniari, Ida Ayu Ika
Saputra, Herman
Arijana, I. Gusti Kamasan Nyoman
BALI MEDICAL JOURNAL, 2020, 9 (03) : 820 - 823
[34] Outcome of patients with IDH1/2-mutated post myeloproliferative neoplasm AML in the era of IDH inhibitors
Chifotides, Helen T.
Masarova, Lucia
Alfayez, Mansour
Daver, Naval
Alvarado, Yesid
Jabbour, Elias
Konopleva, Marina
Kantarjian, Hagop M.
Patel, Keyur P.
DiNardo, Courtney D.
Verstovsek, Srdan
BLOOD ADVANCES, 2020, 4 (21) : 5336 - 5342
[35] IDH1/IDH2 mutations predict survival in glioma and AML
Hegi, M.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S2 - S2
[36] IDH-mutant glioma: A new IDH1 inhibitor moves forward
Miller, Julie J.
Arrillaga-Romany, Isabel
NEURO-ONCOLOGY, 2023, 25 (02) : 337 - 338
[37] IDH1 and IDH2 hotspot mutations are not found in canine glioma
Reitman, Zachary J.
Olby, Natasha J.
Mariani, Christopher L.
Thomas, Rachael
Breen, Matthew
Bigner, Darell D.
McLendon, Roger E.
Yan, Hai
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (01) : 245 - 246
[38] Outcome After Hypomethylating Agents Failure in Patients With IDH1 Mutated Myelodysplastic Syndromes
Abuhelwa, Ziad
Al Ali, Najla
Xie, Zhuoer
Chan, Onyee
Seongseok, Yun
Kuykendall, Andrew
Walker, Alison
Lancet, Jeffrey
Padron, Eric
Sallman, David
Komrokji, Rami
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S391 - S391
[39] Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation; [Rezidivmuster bei Patienten mit anaplastischem Glioma mit einer IDH1/2-Mutation]
Back M.
Jayamanne D.
Brazier D.
Newey A.
Bailey D.
Schembri G.
Hsiao E.
Khasraw M.
Wong M.
Kastelan M.
Brown C.
Wheeler H.
Strahlentherapie und Onkologie, 2020, 196 (1) : 31 - 39
[40] Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia
Lu, Jingtao
Chen, Meiyu
Hua, Haiying
Qin, Wei
Zhang, Ri
Lu, Xuzhang
Chao, Hongying
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (06) : 1483 - 1490

← 1 2 3 4 5 →